Antitumor agent-176 (Compound 22), an antitumor agent, can effectively bind to FGF2 and inhibit the activation of fibroblast growth factor receptor (FGFR) in multiple myeloma (MM) cells, exhibiting significant antitumor activity both in vivo and in vitro against MM[1].
Molecular Weight:
430.34
Formula:
C21H16F6O3
Target:
FGFR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted